LSE - Delayed Quote GBp

Cel AI PLC (CLAI.L)

0.2000
-0.0250
(-11.11%)
As of 3:36:55 PM GMT+1. Market Open.
Loading Chart for CLAI.L
  • Previous Close 0.2250
  • Open 0.2500
  • Bid 0.2000 x --
  • Ask 0.2500 x --
  • Day's Range 0.2000 - 0.2500
  • 52 Week Range 0.0300 - 0.6000
  • Volume 1,506,250
  • Avg. Volume 3,417,319
  • Market Cap (intraday) 1.204M
  • Beta (5Y Monthly) -0.16
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare products. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United Kingdom.

www.getcel.ai

1

Full Time Employees

August 31

Fiscal Year Ends

Recent News: CLAI.L

View More

Performance Overview: CLAI.L

Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

CLAI.L
150.00%
FTSE 100 (^FTSE)
5.20%

1-Year Return

CLAI.L
42.86%
FTSE 100 (^FTSE)
1.95%

3-Year Return

CLAI.L
90.00%
FTSE 100 (^FTSE)
18.87%

5-Year Return

CLAI.L
99.00%
FTSE 100 (^FTSE)
43.43%

Compare To: CLAI.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLAI.L

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    1.36M

  • Enterprise Value

    1.14M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    75.52

  • Price/Book (mrq)

    2.63

  • Enterprise Value/Revenue

    63.62

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -71.30%

  • Return on Equity (ttm)

    -131.60%

  • Revenue (ttm)

    17.94k

  • Net Income Avi to Common (ttm)

    -1.83M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    213.63k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -834.28k

Research Analysis: CLAI.L

View More

Company Insights: CLAI.L

Research Reports: CLAI.L

View More

People Also Watch